MITNF yields 1.26% · MRK yields 2.76%● Live data
📍 MITNF pulled ahead of the other in Year 4
Combined, MITNF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MITNF + MRK for your $10,000?
Mi Technovation Berhad, an investment holding company, designs, develops, manufactures, and sells wafer level chip scale packaging (WLCSP) sorting machines for the semiconductor industry in Southeast Asia, Northeast Asia, and North Atlantic. The company operates through three segments: Semiconductor Equipment Business Unit, Semiconductor Material Business Unit, and Others. It offers Mi series product for advanced packaging and die sorting tape and reel machine with vision inspection for smartphones, tablets, wireless wearable devices, Bluetooth, near field sensing, and sensor applications; and Vi series product for wafer and package inspection in 2D and 3D mode for telecommunication and IoT industries. The company also provides Ai series product, a precision bonding machine for extra fine pitch with think die and substrate thickness used in server in telecommunications industry, GPU and CPU for high performance computing application in AI and blockchain, and image sensor and memory applications; and Si series, a final test equipment for high power and fine pitch devices used in electric vehicles and telecommunications applications. It is also involved in the provision of maintenance services and technical support for its machines; sale of related spare parts and components; and manufacture and sale of solder spheres and other semiconductor-related materials. The company was formerly known as Mi Equipment Holdings Berhad and changed its name to Mi Technovation Berhad in December 2018. Mi Technovation Berhad was founded in 2007 and is headquartered in Bayan Lepas, Malaysia.
Full MITNF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.